Kingworld Medicines Group Ltd. (HK:1110) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kingworld Medicines Group Ltd. has announced its Board of Directors as of September 1, 2024, which includes both executive and independent non-executive members. The board comprises seven individuals with Mr. Zhao Li Sheng as the Chairman and roles distributed across three key committees: Audit, Remuneration, and Nomination. This restructuring reflects Kingworld’s commitment to strong governance and oversight in its operations.
For further insights into HK:1110 stock, check out TipRanks’ Stock Analysis page.